IVABRADINE GPPL ivabradine (as hydrochloride) 7.5 mg tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

ivabradine hydrochloride, Quantity: 8.085 mg (Equivalent: ivabradine, Qty 7.5 mg)

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; maltodextrin; magnesium stearate; maize starch; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000

Ievadīšanas:

Oral

Vienības iepakojumā:

56, 14

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Treatment of chronic stable angina Symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers, OR in combination with atenolol 50mg once daily when angina is inadequately controlled.,Treatment of chronic heart failure Treatment of symptomatic chronic heart failure of NYHA Classes II or III and with documented left ventricular ejection fraction (LVEF) ? 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

Produktu pārskats:

Visual Identification: Ivabradine 7.5 mg is light salmon, round (7 mm diameter), biconvex film-coated tablet.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

2018-01-11